Belief Biomed Inc.

Shanghai Belief BioMed’s (BBM) gene therapy, BBM-H901, an adeno-associated virus vector (AAV) carrying the human factor IX (FIX) gene, has shown favorable efficacy and safety in adults with hemophilia

Banking on speedy domestic clinical progress and low costs, Chinese developers of innovative drugs for rare diseases are calling time on the rarity of their go-global breakthroughs. Over the past few

Riding China’s supportive policies for rare disease and breakthrough therapies, including cell and gene therapies, Takeda Pharmaceutical Co. Ltd. has deepened its Chinese pharma industry ties by obt

After leading a Nasdaq-listed Chinese biotech, I-Mab Biopharma Co., Ltd , as CEO for years, Joan Shen has started and is CEO of her own new bioventure, NeuShen Therapeutics, which is focusing on cent